These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 19800187

  • 1. Noninvasive assessment of fibrosis and steatosis in NASH and ASH.
    Angulo P.
    Gastroenterol Clin Biol; 2009; 33(10-11):940-8. PubMed ID: 19800187
    [Abstract] [Full Text] [Related]

  • 2. Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future.
    Wieckowska A, McCullough AJ, Feldstein AE.
    Hepatology; 2007 Aug; 46(2):582-9. PubMed ID: 17661414
    [Abstract] [Full Text] [Related]

  • 3. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.
    McPherson S, Stewart SF, Henderson E, Burt AD, Day CP.
    Gut; 2010 Sep; 59(9):1265-9. PubMed ID: 20801772
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease.
    Palekar NA, Naus R, Larson SP, Ward J, Harrison SA.
    Liver Int; 2006 Mar; 26(2):151-6. PubMed ID: 16448452
    [Abstract] [Full Text] [Related]

  • 6. Non-alcoholic steatohepatitis in children.
    Nanda K.
    Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
    [Abstract] [Full Text] [Related]

  • 7. [Aspartate aminotransferase (AST) more than alanine aminotransferase (ALT) levels predict the progression of liver fibrosis in chronic HCV infection].
    Stránský J, Ryzlová M, Striteský J, Horák J.
    Vnitr Lek; 2002 Oct; 48(10):924-8. PubMed ID: 16737138
    [Abstract] [Full Text] [Related]

  • 8. Noninvasive assessment of liver fibrosis.
    Martínez SM, Crespo G, Navasa M, Forns X.
    Hepatology; 2011 Jan; 53(1):325-35. PubMed ID: 21254180
    [Abstract] [Full Text] [Related]

  • 9. [Comparison of various noninvasive serum markers of liver fibrosis in chronic viral liver disease].
    Kim SM, Sohn JH, Kim TY, Roh YW, Eun CS, Jeon YC, Han DS, Oh YH.
    Korean J Hepatol; 2009 Dec; 15(4):454-63. PubMed ID: 20037264
    [Abstract] [Full Text] [Related]

  • 10. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.
    Ong JP, Elariny H, Collantes R, Younoszai A, Chandhoke V, Reines HD, Goodman Z, Younossi ZM.
    Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462
    [Abstract] [Full Text] [Related]

  • 11. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
    Ito S, Yukawa T, Uetake S, Yamauchi M.
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hyaluronic acid levels can predict severe fibrosis and platelet counts can predict cirrhosis in patients with nonalcoholic fatty liver disease.
    Kaneda H, Hashimoto E, Yatsuji S, Tokushige K, Shiratori K.
    J Gastroenterol Hepatol; 2006 Sep; 21(9):1459-65. PubMed ID: 16911693
    [Abstract] [Full Text] [Related]

  • 14. Serum hyaluronic acid for the screening of progressive nonalcoholic steatohepatitis in children: a promising approach.
    Valenti L, Dongiovanni P.
    Transl Res; 2010 Oct; 156(4):226-8. PubMed ID: 20875898
    [Abstract] [Full Text] [Related]

  • 15. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years.
    Wong VW, Wong GL, Choi PC, Chan AW, Li MK, Chan HY, Chim AM, Yu J, Sung JJ, Chan HL.
    Gut; 2010 Jul; 59(7):969-74. PubMed ID: 20581244
    [Abstract] [Full Text] [Related]

  • 16. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease.
    Sorbi D, Boynton J, Lindor KD.
    Am J Gastroenterol; 1999 Apr; 94(4):1018-22. PubMed ID: 10201476
    [Abstract] [Full Text] [Related]

  • 17. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD).
    Yoneda M, Yoneda M, Mawatari H, Fujita K, Endo H, Iida H, Nozaki Y, Yonemitsu K, Higurashi T, Takahashi H, Kobayashi N, Kirikoshi H, Abe Y, Inamori M, Kubota K, Saito S, Tamano M, Hiraishi H, Maeyama S, Yamaguchi N, Togo S, Nakajima A.
    Dig Liver Dis; 2008 May; 40(5):371-8. PubMed ID: 18083083
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non-alcoholic fatty liver disease patients.
    Manousou P, Kalambokis G, Grillo F, Watkins J, Xirouchakis E, Pleguezuelo M, Leandro G, Arvaniti V, Germani G, Patch D, Calvaruso V, Mikhailidis DP, Dhillon AP, Burroughs AK.
    Liver Int; 2011 May; 31(5):730-9. PubMed ID: 21457446
    [Abstract] [Full Text] [Related]

  • 20. Usefulness of a combined evaluation of the serum adiponectin level, HOMA-IR, and serum type IV collagen 7S level to predict the early stage of nonalcoholic steatohepatitis.
    Shimada M, Kawahara H, Ozaki K, Fukura M, Yano H, Tsuchishima M, Tsutsumi M, Takase S.
    Am J Gastroenterol; 2007 Sep; 102(9):1931-8. PubMed ID: 17511754
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.